comparemela.com

Latest Breaking News On - Medical pharmaceuticals - Page 5 : comparemela.com

Global Atherectomy Devices Market Report 2023-2030: Minimally Invasive Treatment Options Surge in Demand, Key Players Boston Scientific, Abbott, and Medtronic Shape the Landscape

/PRNewswire/ The "Atherectomy Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity.

New zealandUnited statesSouth koreaSaudi arabiaSouth africaUnited kingdomAsia pacificLaura woodWorld health organizationResearch institutesAustralian bureau of statisticsCare serviceTerumo corporationAbbott laboratoriesCardinal healthOpportunity company analysis

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021）

/PRNewswire/ On January 9, 2024 (Beijing Time), Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor.

Hong kongEuropean unionAbbisko therapeutics co ltdEuropean medicines agencyHong kong stock exchangeAbbisko cayman limited stock codeBeijing timeAbbisko therapeuticsPriority medicinesBreak through designationFast track designationAbbisko cayman limitedStock codeHealth care amp hospitalsMedical pharmaceuticals

NSF SleepTech Award Winner Embr Labs showcased at CES Conference

/PRNewswire/ Embr Labs, named as a winner in the National Sleep Foundation s (NSF) 2023 SleepTech® Award, will be featured by National Sleep Foundation.

United statesLas vegasJohn loposNational sleep foundationSleep foundationSleeptech awardSleep healthSleep disordersEmbr waveSam shamesTech awardEmbr labsMedical pharmaceuticalsHealth care amp hospitalsTrade show news

Preeclampsia Foundation and Society for Maternal-Fetal Medicine Unveil Visual Patient Experience Tools

/PRNewswire/ Today, the Preeclampsia Foundation (PF) and the Society for Maternal-Fetal Medicine (SMFM) unveiled a new "Make Preeclampsia History" patient.

Judette louisKerri wadeAshanti gardnerLaney poyeJacqueline parchemSociety for maternalPreeclampsia foundationLeading preeclampsia advocates partnerLaunch new educationalMaternal fetal medicineHistory monthPreeclampsia foundation directorCommunications laneyHealth care amp hospitalsSupplementary medicineMedical pharmaceuticals

Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution

New collaborative research center based at University of California, Berkeley, plans to develop platform approaches that can be easily modified to develop.

United statesLawrence livermore national laboratorySan franciscoBrad ringeisenLos angelesRainer blairLeica biosystemsLeica microsystemsFyodor urnovJennifer doudnaLawrence berkeley national laboratoryBeckman coulter life sciencesPrnewswire danaher corporationInnovative genomics instituteUniversity of californiaDanaher beacon

vimarsana © 2020. All Rights Reserved.